Phase I/II trial of reovirus and gemcitabine in patients with metastatic solid tumours.
Phase of Trial: Phase I/II
Latest Information Update: 13 Apr 2011
At a glance
- Drugs Gemcitabine; Pelareorep
- Indications Lung cancer; Ovarian cancer; Pancreatic cancer
- Focus Adverse reactions
- 13 Apr 2011 Status changed from active, no longer recruiting to completed.
- 01 Jun 2009 Interim results presented at the American Society of Clinical Oncology (ASCO) 2009 annual meeting, according to an Oncolytics Biotech media release.
- 25 Mar 2009 Status changed from recruiting to active, no longer recruiting as reported by Oncolytics Biotech.